Probiotics in the Treatment of Irritable Bowel Syndrome

Last updated: April 22, 2013
Sponsor: Isfahan University of Medical Sciences
Overall Status: Completed

Phase

2/3

Condition

Lactose Intolerance

Gastrointestinal Diseases And Disorders

Colic

Treatment

N/A

Clinical Study ID

NCT01837472
390506
  • Ages 18-65
  • All Genders

Study Summary

Evidence have shown benefits of gut flora modulation in treatment of irritable bowel syndrome (IBS), but few reports are available on the effects of multistrain probiotics and there are few reports available in this regard from our society. Thus, we investigated if probiotics are effective in our patients as well. We hypothesize that the multistrain probiotic Balance containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains, and Streptococcus thermophiles reduces the symptoms of irritable bowel syndrome.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age between 18 and 65

  • diagnosis of IBS based on the Rome III criteria

  • willingness to participate

Exclusion

Exclusion Criteria:

  • receiving other probiotics compound during the study

  • receiving antibiotics during the study

Study Design

Total Participants: 132
Study Start date:
April 01, 2012
Estimated Completion Date:
April 30, 2013

Connect with a study center

  • Department of Gastroenterology, Alzahra Hospital

    Isfahan, 81746-73461
    Iran, Islamic Republic of

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.